Final answer:
Zio AT can notify physicians up to 30 days sooner than other MCTs for the early detection of abnormal heart rhythms such as Atrial Fibrillation (AFib).
Step-by-step explanation:
Zio AT is a type of wearable electrocardiogram (ECG) patch that can detect abnormal heart rhythms, such as Atrial Fibrillation (AFib), which can increase the risk of stroke. By continuously monitoring the heart, Zio AT can provide physicians with early detection of these conditions, allowing them to intervene and provide appropriate treatment up to 30 days sooner than traditional Holter monitors.
This early detection is crucial because it can help prevent serious complications and improve patient outcomes. For example, if a patient is experiencing silent AFib that goes undetected, they may be at a higher risk of stroke. However, if Zio AT can detect it early, the patient can be prescribed anticoagulant medication to prevent blood clots and reduce the risk of stroke.